The FDA recently added non-GLP peptides to the 503A and 503B compounding framework, bringing much-needed clarity and safety to the industry. Discover what this regulatory shift means for your treatment and how Mantality Health continues to lead with clinical integrity, transparency, and world-class sourcing standards.